Calcium and Phosphate Regulation Summary
Calcium and Phosphate Regulation
Distribution of Calcium
Calcium is primarily stored in bones (99%), with smaller amounts in intracellular fluid (ICF) and extracellular fluid (ECF).
Total plasma calcium: 9-10.5 mg/dl
Forms of calcium in ECF/Plasma:
Non-diffusible (protein-bound): 41% (primarily albumin)
Diffusible (ionized and complexed to anions): 59%
Includes calcium complexed with bicarbonate, citrate, phosphate
Ionized calcium is the physiologically active form.
Calcium Functions
Muscle contraction (skeletal, cardiac, smooth)
Blood clotting: Activates clotting factors.
Nerve impulse transmission: Influences neurotransmitter release and neuronal excitability.
Bone formation: Important for hydroxyapatite crystal formation
Second messenger in signaling pathways: e.g., calmodulin activation
Enzyme cofactor: Participates in enzymatic reactions
Stabilizing resting membrane potential:
Serum membrane excitability (hypocalcemia leads to tetany)
Serum membrane excitability (hypercalcemia leads to muscle weakness)
Non-ionized vs. Ionized Calcium
Non-ionized Calcium:
Bound to proteins (albumin) and complexed with anions.
Serves as a reserve.
Ionized Calcium:
Free calcium, biologically active.
Crucial for muscle contraction, nerve function, blood clotting, and enzyme activity.
Calcium and Albumin Binding
Binding is pH-dependent.
Alkalosis: Low ionized (more protein binding)
Acidosis: High ionized (less protein binding)
Phosphate
Plasma concentration: ~4 mg/dL.
Essential for ATP, cAMP, phospholipid bilayer, and nucleic acid structure.
Forms: Ionized (50%) and Un-ionized (50%).
Tightly regulated with calcium.
Effects of Altered Calcium and Phosphate
Slight changes in calcium can cause immediate physiological effects.
Chronic hypo-calcemia or hypo-phosphatemia decreases bone mineralization, leading to osteomalacia or rickets.
Hypocalcemia
Increases nerve excitability due to increased neuronal membrane permeability to sodium ions.
Symptoms: tetany, paresthesias, spasms, seizures, Chvostek's and Trousseau's signs.
Hypercalcemia
Decreases nerve excitability (decreased sodium permeability).
Symptoms: Stones (kidney stones), bones (bone pain), groans (abdominal pain, constipation), thrones (polyuria), psychiatric overtones (anxiety, cognitive dysfunction).
Vitamin D
Promotes calcium absorption in the intestine by increasing the production of calcium-binding proteins.
Promotes bone calcification in smaller quantities.
Extreme quantities cause bone absorption by increasing osteoclast activity.
Parathyroid Hormone (PTH)
Increases plasma calcium levels and decreases phosphate levels.
Acts on kidneys, bone, and intestine.
Increases calcium and phosphate resorption from bone (activates osteoclasts).
Calcitonin
Decreases blood calcium and phosphate levels.
Opposite effect to PTH; inhibits osteoclast activity.
Bone Cells
Osteoblasts: Bone forming cells; synthesize and secrete bone matrix (osteoid).
Osteocytes: Osteoblasts surrounded by calcified matrix; sense mechanical stress and regulate bone remodeling.
Osteoclasts: Bone eroding cells; resorb bone by secreting acids and enzymes.
Bone Turnover
RANK/RANK-L/OPG system regulates osteoclast activity.
More RANK-L/MCSF More osteoclast activity
More OPG Less osteoclast activity
Bone Formation
Wolf's Law: Bones become thicker and stronger with stress, and thinner and weaker without stress; bone adapts to mechanical loading.
Vitamin D Metabolism
Vitamin D Liver (25-hydroxycholecalciferol) Kidney (1,25-dihydroxycholecalciferol/calcitriol).
PTH stimulates 1α-hydroxylase in the kidney to produce calcitriol.
PTH Regulation
Decreased extracellular calcium Increased PTH secretion.
Calcium-sensing receptor (CaSR) in parathyroid cells detects calcium levels; regulates PTH secretion based on serum calcium.